Tennessee classifies gabapentin as a Schedule V controlled substance under state law, a designation enacted in 2018 through an amendment to the Tennessee Controlled Substances Act. Gabapentin is classified as a controlled substance in several states, including Alabama, Georgia, Kentucky, Tennessee, and Texas. These states have placed it under Schedule V, indicating a lower potential for abuse compared to higher schedules. 2021 Tennessee Code Title 39 - Criminal Offenses Chapter 17 - Offenses Against Public Health, Safety and Welfare Part 4 - Drugs § 39-17-414. Controlled Substances in Schedule v June 21, 2018 Effective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. It is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. Gabapentin is often used to potentiate the effects of opioids and potentially increases the risk of overdose death when used in combination with them. The US [] Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). Gabapentin Becomes Controlled Substance on July 1, 2018 Eff ective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. Known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex, gabapentin is often used to potentiate the eff ects of opioids and potentially increases the risk of overdose death when used in combination (a) Schedule III consists of the drugs and other substances by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. (b) Stimulants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on Except when dispensed directly by a health care prescriber other than a pharmacy to an ultimate user, no controlled substance in Schedule II may be dispensed without the electronic prescription of a health care prescriber, unless authorized by § 63-1-160. To the extent federal law does not permit an electronic prescription, a written prescription from a health care prescriber is required. In This commentary summarizes gabapentin's abuse potential, identifies state-level actions regarding gabapentin monitoring, and discusses possible clinical implications and ways to enhance patient safety when prescribing gabapentin. Is Gabapentin a Controlled Substance in Tennessee and does it require a DEA to prescribe? Gabapentin is a Schedule V Controlled Substance in Tennessee and therefore should be treated just like any other Schedule V Controlled Substance. Prescription Drug Misuse and Abuse The Tennessee (TN) Controlled Substance Monitoring Database (CSMD) is a Prescription Drug Monitoring Program (PDMP) designed to provide healthcare practitioners with a comprehensive view of a patient’s history of controlled substance prescriptions. The CSMD collects prescriptions from pharmacies licensed by the Tennessee Board of Pharmacy, as well as human Controlled Substance in Tennessee July 1, 2018 Effective July 1, 2018, all gabapentin products became Schedule V controlled substances in the state of Tennessee. Gabapentin is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. Gabapentin is often used to potentiate the effects of opioids and potentially increases the risk of overdose death when used in Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. Effective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. It is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. > General Pharmacy News > Drug Updates > Gabapentin Becomes Controlled Substance on July 1, 2018 > gabapentin_schedule_v175X100 June 21, 2018 (d) Depressants, unless specifically exempted or excluded or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts: THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND SUBSTANCE ABUSE SERVICES DIVISION OF SUBSTANCE ABUSE SERVICES An authorized healthcare practitioner's delegate may check the controlled substance database on behalf of the healthcare practitioner. A "new episode of treatment" means a prescription for a controlled substance that has not been prescribed by that healthcare practitioner within the previous six (6) months. Gabapentin isn’t considered a controlled substance by the federal government as of July 2022. But several states consider gabapentin a schedule V (schedule 5) controlled substance. The Tennessee (TN) Controlled Substance Monitoring Database (CSMD) is a Prescription Drug Monitoring Program (PDMP) designed to provide healthcare practitioners with a comprehensive view of a patient’s history of controlled substance prescriptions.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |